References
- 1. Paniagua L, Lohsoonthorn V, Lertmaharit S, Jiamjarasrangsi W, Williams MA. Comparison of waist circumference, body mass index, percent body fat and other measure of adiposity in identifying cardiovascular disease risks among Thai adults. Obesity Res Clin Pract. 2008; 2:215-23.10.1016/j.orcp.2008.05.003362742323599834
- 2. World Health Organization. Cardiovascular Diseases. Geneva: World Health Organization; [cited 2009].
- 3. Bureau of Health Policy and Plan, Office of Permanent Secretary, Ministry of Public Health. Thailand Health Profile 1997-1998. Bangkok: Printing Press, Express Transportation Organization, 2000.
- 4. Hassinen M, Lakka TA, Komulainen P, Gylling H, Nissinen A, Rauramaa R. C-reactive protein and metabolic syndrome in elderly women: a 12-year follow-up study. Diabetes Care. 2006; 29:931-2.10.2337/diacare.29.04.06.dc05-250816567842
- 5. Lee JG, Lee S, Kim YJ, Jin HK, Cho BM, Jeong DW, et al. Multiple biomarkers and their relative contributions to identifying metabolic syndrome. ClinChim Acta. 2009; 408:50-5.10.1016/j.cca.2009.07.00619622349
- 6. Okosun IS. Metabolic syndrome and C-reactive protein in American adults: the impact of abdominal obesity. Metab Syndr Relat Disord. 2008; 6:289-97.10.1089/met.2008.004019067532
- 7. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002; 287:356-9.10.1001/jama.287.3.35611790215
- 8. Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation. 2003; 107:391-7.10.1161/01.CIR.0000055014.62083.05
- 9. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome-a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med. 2006; 23:469-80.10.1111/j.1464-5491.2006.01858.x16681555
- 10. Nash DT. Relationship of C-reactive protein, metabolic syndrome and diabetes mellitus: potential role of statins. J Natl Med Assoc. 2005; 97:1600-7.
- 11. Osman R, L’Allier PL, Elgharib N, Tardif JC. Critical appraisal of C-reactive protein throughout the spectrum of cardiovascular disease. Vasc Health Risk Manag. 2006; 2:221-37.10.2147/vhrm.2006.2.3.221199397917326329
- 12. Ridker PM, Buring JE, Shih J, Matias M, Hennekens CH. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation. 1998; 98:731-3.10.1161/01.CIR.98.8.731
- 13. Castell JV, Gomez-Lechon MJ, David M, Fabra R, Trullenque R, Heinrich PC. Acute-phase response of human hepatocytes: regulation of acute-phase protein synthesis by interleukin-6. Hepatology. 1990; 12: 1179-86.10.1002/hep.18401205171699862
- 14. Mohamed-Ali V, Pinkney JH, Coppack SW. Adipose tissue as an endocrine and paracrine organ. Int J Obes Relat Metab Disord. 1998; 22:1145-58.10.1038/sj.ijo.0800770
- 15. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW. Creactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol. 1999; 19:972-8.10.1161/01.ATV.19.4.972
- 16. Musunuru K, Kral BG, Blumenthal RS, Fuster V, Campbell CY, Gluckman TJ, et al. The use of highsensitivity assays for C-reactive protein in clinical practice. Nat Clin Pract Cardiovasc Med. 2008; 5: 621-35.10.1038/ncpcardio1322
- 17. Wang J, Thornton JC, Bari S, Williamson B, Gallagher D, Heymsfield SB, et al. Comparisons of waist circumferences measured at 4 sites. Am J Clin Nutr. 2003; 77:379-84.10.1093/ajcn/77.2.379
- 18. NCEP. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001; 285:2486-97.10.1001/jama.285.19.2486
- 19. Shiwaku K, Anuurad E, Enkhmaa B, Kitajima K, Yamane Y. Appropriate BMI for Asian populations. Lancet. 2004; 363:1077.10.1016/S0140-6736(04)15856-X
- 20. Rothman KJ, Greenland S, Lash TL. Modern epidemiology. 3rd ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2008.
- 21. Aronson D, Sella R, Sheikh-Ahmad M, Kerner A, Avizohar O, Rispler S, et al. The association between cardiorespiratory fitness and C-reactive protein in subjects with the metabolic syndrome. J Am Coll Cardiol. 2004; 44:2003-7.10.1016/j.jacc.2004.08.03015542283
- 22. Laaksonen DE, Niskanen L, Nyyssonen K, Punnonen K, Tuomainen TP, Valkonen VP, et al. C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men. Diabetologia. 2004; 47: 1403-10.10.1007/s00125-004-1472-x15309290
- 23. Saltevo J, Vanhala M, Kautiainen H, Kumpusalo E, Laakso M. Association of C-reactive protein, interleukin-1 receptor antagonist and adiponectin with the metabolic syndrome. Mediators Inflamm. 2007; 2007:93573.10.1155/2007/93573222266618288276
- 24. Chapidze G, Dolidze N, Enquobahrie DA, Kapanadze S, Latsabidze N, Williams MA. Metabolic syndrome and C-reactive protein among cardiology patients. Arch Med Res. 2007; 38:783-8.10.1016/j.arcmed.2007.03.01117845899
- 25. Ford ES, Ajani UA, Mokdad AH. The metabolic syndrome and concentrations of C-reactive protein among US youth. Diabetes Care. 2005; 28:878-81.10.2337/diacare.28.4.87815793189
- 26. Lee WY, Park JS, Noh SY, Rhee EJ, Sung KC, Kim BS, et al. C-reactive protein concentrations are related to insulin resistance and metabolic syndrome as defined by the ATP III report. Int J Cardiol. 2004; 97:101-6.10.1016/j.ijcard.2003.08.01615336815
- 27. Rutter MK, Meigs JB, Sullivan LM, D’Agostino RB, Sr., Wilson PW. C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study. Circulation. 2004; 110:380-5.10.1161/01.CIR.0000136581.59584.0E15262834
- 28. Yan E, Chen S, Hong K, Kim WS, Bajpai A, Treyzon L, et al. Insulin, hs-CRP, leptin, and adiponectin. An analysis of their relationship to the metabolic syndrome in an obese population with an elevated waist circumference. Metab Syndr Relat Disord. 2008; 6: 64-73.10.1089/met.2007.002718370838
- 29. Paoletti R, Bolego C, Poli A, Cignarella A. Metabolic syndrome, inflammation and atherosclerosis. Vasc Health Risk Manag. 2006; 2:145-52.10.2147/vhrm.2006.2.2.145199399217319458